128 related articles for article (PubMed ID: 34488577)
1. RNA Aptamers for Theranostics of Glioblastoma of Human Brain.
Kopylov AM; Fab LV; Antipova O; Savchenko EA; Revishchin AV; Parshina VV; Pavlova SV; Kireev II; Golovin AV; Usachev DY; Pavlova GV
Biochemistry (Mosc); 2021 Aug; 86(8):1012-1024. PubMed ID: 34488577
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of EGFR expression using an
Cheng S; Jacobson O; Zhu G; Chen Z; Liang SH; Tian R; Yang Z; Niu G; Zhu X; Chen X
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):948-956. PubMed ID: 30069577
[TBL] [Abstract][Full Text] [Related]
3. [Is it possible to detect surface antigen CD133 on patient-derived glioblastoma continuous cell cultures using fluorescent aptamers?].
Moiseenko VL; Antipova OM; Pavlova SA; Pronin IN; Pavlova GV; Kopylov AM
Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(1):56-62. PubMed ID: 38334731
[TBL] [Abstract][Full Text] [Related]
4. DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro.
Tan Y; Shi YS; Wu XD; Liang HY; Gao YB; Li SJ; Zhang XM; Wang F; Gao TM
Acta Pharmacol Sin; 2013 Dec; 34(12):1491-8. PubMed ID: 24304919
[TBL] [Abstract][Full Text] [Related]
5. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
6. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell proliferation by an anti-EGFR aptamer.
Li N; Nguyen HH; Byrom M; Ellington AD
PLoS One; 2011; 6(6):e20299. PubMed ID: 21687663
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.
van de Water JA; Bagci-Onder T; Agarwal AS; Wakimoto H; Roovers RC; Zhu Y; Kasmieh R; Bhere D; Van Bergen en Henegouwen PM; Shah K
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16642-7. PubMed ID: 23012408
[TBL] [Abstract][Full Text] [Related]
9. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme.
Liu KJ; Chen CT; Hu WS; Hung YM; Hsu CY; Chuang BF; Juang SH
Int J Oncol; 2004 Mar; 24(3):581-90. PubMed ID: 14767543
[TBL] [Abstract][Full Text] [Related]
11. Surface-immobilized aptamers for cancer cell isolation and microscopic cytology.
Wan Y; Kim YT; Li N; Cho SK; Bachoo R; Ellington AD; Iqbal SM
Cancer Res; 2010 Nov; 70(22):9371-80. PubMed ID: 21062984
[TBL] [Abstract][Full Text] [Related]
12. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.
Keir ST; Chandramohan V; Hemphill CD; Grandal MM; Melander MC; Pedersen MW; Horak ID; Kragh M; Desjardins A; Friedman HS; Bigner DD
J Neurooncol; 2018 Jul; 138(3):489-498. PubMed ID: 29564747
[TBL] [Abstract][Full Text] [Related]
13. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma.
Cesarini V; Scopa C; Silvestris DA; Scafidi A; Petrera V; Del Baldo G; Gallo A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32957732
[TBL] [Abstract][Full Text] [Related]
15. Pyrene-Modified DNA Aptamers with High Affinity to Wild-Type EGFR and EGFRvIII.
Zavyalova E; Turashev A; Novoseltseva A; Legatova V; Antipova O; Savchenko E; Balk S; Golovin A; Pavlova G; Kopylov A
Nucleic Acid Ther; 2020 Jun; 30(3):175-187. PubMed ID: 31990606
[TBL] [Abstract][Full Text] [Related]
16. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
[TBL] [Abstract][Full Text] [Related]
17. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
[TBL] [Abstract][Full Text] [Related]
18. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
[TBL] [Abstract][Full Text] [Related]
19. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
20. Epidermal Growth Factor (EGF) Augments the Invasive Potential of Human Glioblastoma Multiforme Cells via the Activation of Collaborative EGFR/ROS-Dependent Signaling.
Pudełek M; Król K; Catapano J; Wróbel T; Czyż J; Ryszawy D
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
